# Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sodium-glucose-co-transporter-2-inhibitors-an-emerging-new-class-of-oral/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Iskandar Idris,Richard Donnelly |
| Citations | 179 |
| DOI | 10.1111/j.1463-1326.2008.00982.x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1970063460 |
| PMID | 19125776 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Iskandar Idris](https://scholariq.org/researchers/iskandar-idris/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Amino Acid Enzymes and Metabolism](https://scholariq.org/topics/amino-acid-enzymes-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.